NOS3 (nitric oxide synthase 3)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
4846 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Nitric oxide synthase 3 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
NOS3 |
SynonymsGene synonyms aliases
|
ECNOS, eNOS |
ChromosomeChromosome number
|
7 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
7q36.1 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs1549758 |
T>A,C |
Risk-factor, benign |
Missense variant, coding sequence variant, synonymous variant |
rs1799983 |
T>A,G |
Pathogenic, risk-factor, benign |
Missense variant, coding sequence variant |
rs2070744 |
C>G,T |
Protective, risk-factor |
Upstream transcript variant, genic upstream transcript variant, intron variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
miRTarBase ID |
miRNA |
Experiments |
Reference |
MIRT007181 |
hsa-miR-155-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
23108656 |
MIRT017773 |
hsa-miR-335-5p |
Microarray |
18185580 |
MIRT053134 |
hsa-miR-24-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
23774796 |
MIRT053134 |
hsa-miR-24-3p |
Immunocytochemistry, Luciferase reporter assay, qRT-PCR, Western blot |
25920448 |
MIRT732952 |
hsa-miR-200c-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
27917915 |
MIRT735516 |
hsa-miR-543 |
Luciferase reporter assay, qRT-PCR |
26647850 |
MIRT735517 |
hsa-miR-335-3p |
Luciferase reporter assay, qRT-PCR |
26647850 |
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000139 |
Component |
Golgi membrane |
TAS |
|
GO:0001974 |
Process |
Blood vessel remodeling |
ISS |
|
GO:0003100 |
Process |
Regulation of systemic arterial blood pressure by endothelin |
IMP |
8999856 |
GO:0003180 |
Process |
Aortic valve morphogenesis |
ISS |
|
GO:0003180 |
Process |
Aortic valve morphogenesis |
TAS |
29325903 |
GO:0003184 |
Process |
Pulmonary valve morphogenesis |
ISS |
|
GO:0003203 |
Process |
Endocardial cushion morphogenesis |
ISS |
|
GO:0003785 |
Function |
Actin monomer binding |
IPI |
17502619 |
GO:0004517 |
Function |
Nitric-oxide synthase activity |
IBA |
21873635 |
GO:0004517 |
Function |
Nitric-oxide synthase activity |
IDA |
1378832, 7488039, 19666465 |
GO:0004517 |
Function |
Nitric-oxide synthase activity |
IMP |
23707606 |
GO:0005515 |
Function |
Protein binding |
IPI |
11149895, 12446846, 12852865, 12855682, 16234328, 16432212, 17502619, 21163940, 22458338, 23123858, 23397142, 23585225, 25062958, 25241761, 25416956, 32296183, 32814053 |
GO:0005516 |
Function |
Calmodulin binding |
IEA |
|
GO:0005634 |
Component |
Nucleus |
IBA |
21873635 |
GO:0005634 |
Component |
Nucleus |
ISS |
|
GO:0005737 |
Component |
Cytoplasm |
IDA |
9794441 |
GO:0005737 |
Component |
Cytoplasm |
ISS |
|
GO:0005794 |
Component |
Golgi apparatus |
IDA |
25131610 |
GO:0005829 |
Component |
Cytosol |
IBA |
21873635 |
GO:0005829 |
Component |
Cytosol |
TAS |
|
GO:0005856 |
Component |
Cytoskeleton |
IEA |
|
GO:0005886 |
Component |
Plasma membrane |
IBA |
21873635 |
GO:0005886 |
Component |
Plasma membrane |
IDA |
25131610 |
GO:0005886 |
Component |
Plasma membrane |
TAS |
|
GO:0005901 |
Component |
Caveola |
IDA |
17502619, 17848177 |
GO:0006527 |
Process |
Arginine catabolic process |
IBA |
21873635 |
GO:0006527 |
Process |
Arginine catabolic process |
IDA |
1378832, 7488039 |
GO:0006809 |
Process |
Nitric oxide biosynthetic process |
IBA |
21873635 |
GO:0006809 |
Process |
Nitric oxide biosynthetic process |
IDA |
1378832, 7488039 |
GO:0007005 |
Process |
Mitochondrion organization |
ISS |
|
GO:0007263 |
Process |
Nitric oxide mediated signal transduction |
IBA |
21873635 |
GO:0008217 |
Process |
Regulation of blood pressure |
NAS |
7504210 |
GO:0008285 |
Process |
Negative regulation of cell population proliferation |
ISS |
|
GO:0009408 |
Process |
Response to heat |
NAS |
18048451 |
GO:0009725 |
Process |
Response to hormone |
IBA |
21873635 |
GO:0010181 |
Function |
FMN binding |
IBA |
21873635 |
GO:0010181 |
Function |
FMN binding |
NAS |
7488039 |
GO:0010544 |
Process |
Negative regulation of platelet activation |
NAS |
7504210 |
GO:0010628 |
Process |
Positive regulation of gene expression |
ISS |
23583836 |
GO:0012506 |
Component |
Vesicle membrane |
IBA |
21873635 |
GO:0014740 |
Process |
Negative regulation of muscle hyperplasia |
ISS |
|
GO:0014806 |
Process |
Smooth muscle hyperplasia |
ISS |
|
GO:0016491 |
Function |
Oxidoreductase activity |
IBA |
21873635 |
GO:0016709 |
Function |
Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
IBA |
21873635 |
GO:0019430 |
Process |
Removal of superoxide radicals |
IDA |
19666465 |
GO:0020037 |
Function |
Heme binding |
IDA |
7488039 |
GO:0030666 |
Component |
Endocytic vesicle membrane |
TAS |
|
GO:0031284 |
Process |
Positive regulation of guanylate cyclase activity |
IBA |
21873635 |
GO:0031284 |
Process |
Positive regulation of guanylate cyclase activity |
IMP |
17502619 |
GO:0031284 |
Process |
Positive regulation of guanylate cyclase activity |
ISS |
|
GO:0031644 |
Process |
Regulation of nervous system process |
ISS |
|
GO:0032496 |
Process |
Response to lipopolysaccharide |
IBA |
21873635 |
GO:0034405 |
Process |
Response to fluid shear stress |
IEP |
10376603 |
GO:0034617 |
Function |
Tetrahydrobiopterin binding |
IDA |
7488039 |
GO:0034618 |
Function |
Arginine binding |
IDA |
7488039 |
GO:0042311 |
Process |
Vasodilation |
NAS |
7504210, 18048451 |
GO:0043536 |
Process |
Positive regulation of blood vessel endothelial cell migration |
IDA |
23802567 |
GO:0043542 |
Process |
Endothelial cell migration |
IMP |
8999856 |
GO:0045454 |
Process |
Cell redox homeostasis |
TAS |
|
GO:0045747 |
Process |
Positive regulation of Notch signaling pathway |
IC |
23583836 |
GO:0045766 |
Process |
Positive regulation of angiogenesis |
IDA |
23802567 |
GO:0045766 |
Process |
Positive regulation of angiogenesis |
ISS |
|
GO:0045776 |
Process |
Negative regulation of blood pressure |
IBA |
21873635 |
GO:0046870 |
Function |
Cadmium ion binding |
NAS |
7488039 |
GO:0048873 |
Process |
Homeostasis of number of cells within a tissue |
ISS |
|
GO:0050660 |
Function |
Flavin adenine dinucleotide binding |
IBA |
21873635 |
GO:0050660 |
Function |
Flavin adenine dinucleotide binding |
NAS |
7488039 |
GO:0050661 |
Function |
NADP binding |
NAS |
7488039 |
GO:0050999 |
Process |
Regulation of nitric-oxide synthase activity |
TAS |
|
GO:0070168 |
Process |
Negative regulation of biomineral tissue development |
ISS |
|
GO:0097746 |
Process |
Blood vessel diameter maintenance |
ISS |
|
GO:1902042 |
Process |
Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
ISS |
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P29474 |
Protein name |
Nitric oxide synthase, endothelial (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (Endothelial NOS) (eNOS) (NOS type III) (NOSIII) |
Protein function |
Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.; [Isoform eNOS13C]: Lacks eNOS activity, dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1. |
PDB |
1M9J
,
1M9K
,
1M9M
,
1M9Q
,
1M9R
,
1NIW
,
2LL7
,
2MG5
,
2N8J
,
3EAH
,
3NOS
,
4D1O
,
4D1P
,
5UO8
,
5UO9
,
5UOA
,
5UOB
,
5UOC
,
5VVB
,
5VVC
,
5VVD
,
5XOF
,
6AV6
,
6AV7
,
6CIE
,
6CIF
,
6NH1
,
6NH2
,
6NH3
,
6NH4
,
6NH5
,
6NH6
,
6NH7
,
6NH8
,
6NHF
,
6POU
,
6POV
,
6POW
,
6POX
,
6POY
,
6POZ
,
6PP0
,
6PP1
,
6PP2
,
6PP3
,
6PP4
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF02898 |
NO_synthase |
119 → 481 |
Nitric oxide synthase, oxygenase domain |
Domain |
PF00258 |
Flavodoxin_1 |
522 → 698 |
Flavodoxin |
Domain |
PF00667 |
FAD_binding_1 |
751 → 979 |
FAD binding domain |
Domain |
PF00175 |
NAD_binding_1 |
1011 → 1125 |
Oxidoreductase NAD-binding domain |
Domain |
|
Sequence |
|
Sequence length |
1203 |
Interactions |
View interactions |
|
|